Another case of severe allergy to Pfizer vaccine identified in the U.S.

Another case of severe allergy to Pfizer vaccine identified in the U.S.

A health care worker in New York City suffered a severe allergic reaction after being vaccinated against a coronavirus from the U.S. company Pfizer.

According to the newspaper, the medical worker’s condition is now assessed as stable. According to officials, this is the first case of an allergic reaction to the drug in the city.

Guidelines from the federal Centers for Disease Control and Prevention (CDC) recommend that health care workers monitor those who have received the COVID-19 vaccine for 15 minutes after or 30 minutes if they have a history of serious allergies.

It was previously reported that a severe allergic reaction to BioNTech/Pfizer’s coronavirus vaccine was reported in the United States. The allergy developed in an Alaskan health care worker ten minutes after administering the drug.

On December 13, the federal Centers for Disease Control and Prevention (CDC) guidelines approved the use of BioNTech/Pfizer vaccines in the United States in emergency circumstances. Healthcare workers and patients in long-term care facilities are to be vaccinated first.

To date, there are several vaccines against COVID-19 worldwide. Two vaccines are registered in Russia: Sputnik V and EpiVacCorona. In the United States, a vaccine against COVID-19 produced by Pfizer and BioNTech is registered. In addition, a drug developed by Moderna has been approved in the country. The British pharmaceutical company AstraZeneca also announced the beginning of clinical trials of its vaccine combination AZD1222.